The National Institutes of Health’s Heart, Lung, and Blood Institute has awarded Dr. Christie Ballantyne a $6 million grant to begin research to better understand how mutations contribute to atherosclerotic cardiovascular diseases.
Researchers at Baylor College of Medicine have found that troponin I, a protein that is most commonly used to diagnose heart attack, can be detected with a new high-sensitivity assay in adults without prior cardiovascular disease or heart failure.
An international team reports they have been able to open the possibility for treating heart disease by reprograming adult cardiomyocytes to a more fetal cell state.
We’ve all heard the advice to take a fish oil with omega-3 fatty acids to improve heart health, but are you actually getting the benefits they claim to provide? Dr. Christie Ballantyne says probably not.
Researchers have shown that a particular treatment significantly reduced cardiovascular events, including cardiovascular death, in patients who continue to have high triglyceride levels on statin therapy.
